Eulerpool Terminal
The edge that pays for itself.
Current Climb Bio forecasts and price targets in November 2026
Ø Analyst Price Targets
22.60 USD
+105.27 %
Median
21.50 USD
+95.28 %
Max
35.00 USD
Min
17.00 USD
Last Price
11.01 USD
Buy
21
Hold
1
Sell
0
The average target price for Climb Bio is 22.60 USD. (+105.27 % above the current price)
The median price target of Climb Bio is 21.50 USD.
Stock analysts from many renowned investment banks are closely examining the Climb Bio stock. They conclude their professional Climb Bio stock analyses with a clear recommendation for the Climb Bio stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-11-01 | 21 | 1 | 0 | 22.60 USD |
| 2026-10-01 | 20 | 1 | 0 | 22.60 USD |
| 2026-09-01 | 20 | 1 | 0 | 22.60 USD |
| 2026-08-01 | 19 | 1 | 0 | 22.60 USD |
| 2026-07-01 | 20 | 1 | 0 | — |
| 2026-06-01 | 19 | 1 | 0 | — |
Climb Bio Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Climb Bio in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2028e | 1.00 M USD | -93.00 M USD | -1.38 USD |
| 2029e | 6.00 M USD | -119.00 M USD | -1.77 USD |
| 2030e | 68.00 M USD | -125.00 M USD | -1.86 USD |